Acibadem City Clinic Diagnostic And Consultation Center Tokuda EAD

At Acibadem City Clinic Diagnostic And Consultation Center Tokuda EAD, the Digestive System Diseases portfolio focuses on Non-Alcoholic Steatohepatitis (NASH) and Ulcerative Colitis. The studies are designed to assess new treatment options, monitor long-term safety, and better understand how these therapies may help people with chronic inflammatory liver and bowel conditions.

• Evaluating a new therapy for NASH and its impact on liver disease activity
• Assessing long-term safety and effectiveness in Ulcerative Colitis
• Studying treatment approaches for moderate to severe digestive system inflammation

This area reflects active clinical research aimed at improving disease control and supporting patients with ongoing gastrointestinal and liver disorders.

The site’s Immune System Diseases trials include work in Primary Immune thrombocytopenia (ITP) and Ulcerative Colitis, with a focus on helping patients whose immune systems are driving chronic illness. These studies are exploring whether new therapies can improve disease control, reduce symptoms, and maintain safety over time.

• Testing a treatment for Primary Immune thrombocytopenia (ITP)
• Exploring long-term management strategies for immune-related bowel disease
• Evaluating whether novel immune-targeted therapies can improve clinical outcomes

This research supports better options for patients living with persistent autoimmune and inflammatory conditions.

In the Neoplasms area, the clinic is involved in studies of Metastatic hormone-sensitive prostate cancer with high tumor load. The main goal is to compare treatment strategies and determine whether a newer cancer therapy can improve survival and delay disease progression.

• Comparing a new approach with standard prostate cancer treatment
• Assessing whether therapy can extend progression-free and overall survival
• Supporting research in advanced oncology

This work contributes to the development of more effective treatment options for men with advanced cancer.

The Respiratory Tract Diseases studies at this hospital clinic center on Chronic obstructive pulmonary disease (COPD). Researchers are examining whether new inhaled treatment combinations can improve lung function and offer better symptom control for people with chronic breathing problems.

• Testing a new treatment combination for COPD
• Measuring improvements in lung function and daily respiratory control
• Evaluating options that may better support long-term breathing health

The research aims to improve treatment effectiveness for patients living with progressive pulmonary disease.

Within Skin and Connective Tissue Diseases, the site is studying Hidradenitis Suppurativa, a painful inflammatory skin condition. The trials are focused on easing signs and symptoms and evaluating whether targeted therapy can provide better control for patients with moderate to severe disease.

• Assessing a targeted treatment for Hidradenitis Suppurativa
• Measuring improvement in symptoms and disease burden
• Advancing care for chronic dermatologic inflammation

This research supports efforts to find more effective options for patients with difficult-to-treat skin and tissue inflammation.